Patent directory Β· USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12391760
Method of treating primary sclerosing cholangitis
granted -
US 12391642
Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors
granted -
US 12391658
Sulfoxide and sulfone glucokinase activators and methods of use thereof
granted -
US 12391732
Articles comprising a silk polypeptide for antigen delivery
granted -
US 12391739
Method for producing gamma delta T cells
granted -
US 12389889
Mouse having a humanized cluster of differentiation 47 gene
granted -
US 12391765
Methods and materials for assessing response to plasmablast- and plasma cell-depleting therapies
granted -
US 12390453
Method for reducing side effects from administration of phosphodiesterase-4 inhibitors
granted -
US 12390462
Muscarinic acetylcholine M1 receptor antagonists
granted -
US 12390463
Dosage forms and regimens for amino acid compounds
granted -
US 12390427
Plasminogen activator inhibitor-1 (PAI-1) inhibitor and method of use
granted -
US 12389931
Oyster peptide with effect of improving sexual function and preparation method thereof
granted -
US 12391686
Compounds and uses thereof
granted -
US 12390497
Microbial strains for virus inhibition
granted -
US 12391741
T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopeptides and methods of use thereof
granted -
US 12391750
Anti-C1S antibodies and methods of use thereof
granted -
US 12391742
Anti-KRAS-G12D T cell receptors
granted -
US 12390483
Compounds and methods for treating neurological and cardiovascular conditions
granted -
US 12390496
Methods for treating ulcerative colitis
granted -
US 12391643
Substituted amino-thiol and amino-disulfide compounds, and uses thereof
granted -
US 12391753
Antigen binding molecule formats
granted -
US 12391923
SIRPΞ±-silenced natural killer (NK) cells
granted -
US 12390512
Depolymerase capable of degrading extracellular polymeric substances of Klebsiella pneumoniae
granted -
US 12391669
Substituted pyrimidines as IRE1 kinase inhibitors
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β best for looking up a specific filing or applicant portfolio slice.